Recombinant expression by the hybridoma cell line SP2/0 is a relatively simple and cost-effective method for producing monoclonal antibodies intended for use as therapeutic agents in humans. The assay qualification has determined a limit of detection of ~0.1 ng/ml for this kit.
|